Twelve further studies were identified. A total of 28 studies varied considerably in design, exposure indices used, and disease definition. Based on 39 sex-specific estimates and the exposure index current spousal exposure (or nearest equivalent), the meta-analysis gave an overall fixed-effect relative risk estimate of 1.23 (95% confidence interval: 1.16-1.31), with significant (P < .05) heterogeneity. There was no significant heterogeneity by sex, continent, fatality, disease end point, or degree of adjustment for potential confounding factors. Relative risks were less elevated in prospective studies (1.15, 1.06-1.24) than in case-control studies (1.44, 1.22-1.60) or cross-sectional studies (1.40, 1.21-1.61). They also varied by publication year, but with no trend. A significant increase was not seen in studies that excluded smokers of any tobacco (1.07, .97-1.17), but was seen for studies that included pipe-or cigar-only smokers, occasional smokers, or long-term former smokers. No elevation was seen for hemorrhagic stroke. Relative risk estimates were similar using ever rather than current exposure, or total rather than spousal exposure. Eleven studies provided dose-response estimates, the combined relative risk for the highest exposure level being 1.56 (1.37-1.79). Many studies have evident weaknesses, recall bias, and particularly publication bias being major concerns.
Introduction
In 2006, two of us (P.N.L. and B.A.F.) published a review 1 of the evidence then available for a possible association between exposure to environmental tobacco smoke (ETS; passive smoking) and the risk of stroke. Based on 16 studies, we concluded that "the association is only suggestive of a possible causal relationship." Recently, the U.S. Surgeon General 2 considered "the evidence is sufficient to infer a causal relationship," with the estimated risk increase being about 20%-30%. This conclusion relied heavily on a meta-analysis reported in 2011, 3 which included results from 20 studies. Several new studies having since been published, we now update our earlier review. We also compare and contrast our findings with those of other recently published reviews on ETS and stroke.
Materials and Methods
A detailed description of the methods used can be found in our original review. 1 Briefly, the literature searches have been repeated at intervals since the original review, most recently in March 2016, seeking publications describing the results of epidemiological studies relating stroke risk to ETS exposure in never (or nearly never) smokers.
Study details were extracted into a database. Details relating to a varying number of age-adjusted relative risks (RRs) per study were also extracted, including the RR itself and its 95% confidence interval (CI). If necessary, these were estimated using standard methods. 4, 5 In this review, we use the term "relative risk" to include both direct estimates, from prospective studies, and indirect estimates, that is, odds ratios, from case-control or cross-sectional studies.
As before, fixed-effect and random-effects metaanalyses were conducted using standard methods. 6, 7 Due to the marked variability in definitions of exposure and disease used, with some studies presenting multiple results, we defined an order of preference to select RRs for a "principal" meta-analysis. This was based on the type of exposure, then time of exposure, and then disease definition. For type of exposure, the order of preference (highest to lowest) was spouse, household, total, and cotinine. For time of exposure, the order of preference was current, recent, during marriage, ever, and in the past. The disease selected was that shown first in the column "disease" in Table 1 was used. Alternative preferences were used in sensitivity analyses. Unless stated otherwise, the data and meta-analyses presented are based on the "most adjusted" RRs, that is, adjusted for age and the greatest number of additional variables, and on sexspecific estimates where available.
All data entry and meta-analyses were carried out using RoeLee version 3.1 (available from PN Lee Statistics and Computing Ltd, Sutton, Surrey, UK).
Results
Twenty-seven publications are included in this review. A further 17 publications which might be thought relevant were rejected for reasons given in Appendix S1. Apart from the 16 studies included previously, a further 12 were identified meeting the inclusion criteria, with one paper 25 providing results for two distinct studies. Probable overlap in the cases considered by two of the studies in Australia 11, 15 could not be separated out and has been ignored in our analyses.
As shown in Table 1 , seven of the twenty-eight studies were conducted in the United States, six in Australia or New Zealand, six in China, four in Great Britain, three in Japan, one in Greece, and one in seven European countries. Sixteen studies were of prospective design, ten of which considered mortality only and six also nonfatal events. There were five cross-sectional studies of nonfatal events. Seven studies were case-control, one 9 using hospital controls, and the rest were population controls. Three 9, 15, 32 case-control studies involved living cases, three 11, 14, 18 both living and dead cases, and one 21 only dead case. Two studies 11, 18 used proxy informants for patients who had died or could not communicate and also for their matched controls, whereas another two 14,32 similarly used proxy informants for cases but not the controls. In one study, 21 people reporting death were asked about the lifestyle of the decedent and of a living control person known to the informant.
The definition of disease considered varied by study, with eight studies presenting separate results for two or more differing end points. The most common end point named was stroke, in 15 studies. Ischemic stroke was considered in seven studies, cerebrovascular disease in six, subarachnoid hemorrhage in four, and three studies included results specifically for hemorrhagic stroke. The results were also reported in one study each for a range of other end points.
Only nine studies used strict inclusion criteria of never having smoked any tobacco product. 8, 9, 12, 16, 17, 19, 20, 28, 33 Six studies included those who had never smoked cigarettes, but may have included pipe-or cigar-only smokers, 13, 21, 22, 24, 26, 32 with a further six also allowing participants who had smoked cigarettes for only a short time (3 or 6 months) or had smoked less than 100 cigarettes in their lifetime. 11, 15, 23, 27, 31, 34 The remaining studies used criteria based on never a regular smoker, thus including occasional smokers 18, 25 or including those who had quit smoking for at least 5 years 29 or 10 years. 14 Two studies confirmed current nonsmoking by serum cotinine <14.1 ng/mL 20 or <15 ng/mL. 29 Ten studies [9] [10] [11] 15, [22] [23] [24] 26, 29, 33 considered exposure from a smoking spouse, although four of these 11, 15, 22, 33 did not restrict analysis to married subjects. Fourteen studies considered exposure at home, in two only from parents, 11, 15 but in the rest from other household members or more generally. 8, 9, 12, 16, 18, 19, 21, 25, 28, 31, 33 Eleven studies considered an index of "total exposure" based on exposures both inside and outside home. The sources included home, work, travel or leisure, 9 home or work, 14, 27, 31, 32 home, other small spaces, or large indoor areas, 16 spouse, work or childhood, 24 home, work, or other places, 30 home, work, travel, or other, 34 or unspecified exposure. 13, 17 Less commonly studied specific sources of exposure considered included work, 9, 24, 28, 31 travel, 9 leisure, 9 childhood, 24, 28 small spaces other than home, 16 large indoor areas, 16 and the combination of these two. 19 The largest study 10 involved 2609 cases, with six other studies of between 500 and 1000 cases. The smallest study 8 involved 12 cases, with seven studies of less than 100 cases. Table 2 presents the "most adjusted" RR (CI) estimates for the main exposures (spouse, household, total) and the different stroke end points studied. These come from 26 studies. Also shown are two studies that provided no adjusted estimates, one 10 reporting a nonsignificant trend (P > .05) but no actual RR estimates, and the other 30 presenting results allowing derivation only of an unadjusted estimate. These two studies are not considered ‖Numbers of cases in lifelong nonsmokers are the totals in the study; for analyses relating to specific types of disease or specific exposures, numbers may be less than this. Where studies report sex-specific results, sex-specific numbers are shown except for one study (13) where only combined numbers are available. Where studies report results for combined sexes only, combined numbers are shown. ¶Numbers are of CVD; there were 126 cases of SAH. #Incident cases only, restricted to those with first occurrence of the disease or excluding those with history of stroke. **Numbers are of SAH; numbers of ASH not available. † †Numbers are of IST; numbers of TIA were 99 in women and 52 in men. ‡ ‡Numbers are of STR, there were 100 cases of IST. § §Numbers are of STR, there were 31 cases of HS and 109 cases of IST. ‖‖Numbers are of STR, numbers of HS were 26 in men and 6 in women, numbers of IST were 14 in men and 13 in women. ¶ ¶Numbers are of STR, there were 87 cases of SAH, 147 cases of ICH, and 467 cases of CI. ##Numbers are of STR, there were 23 cases of HS and 184 cases of IST. Abbreviations: ETS, environmental tobacco smoke; CI, confidence interval; RR, relative risks. *Term as used by the authors of the paper: ASH, aneurysmal subarachnoid hemorrhage; CI, cerebral infarction; CIS, cerebral ischemia; CVD, cerebrovascular disease; HS, hemorrhagic stroke; ICH, intracerebral hemorrhage; IST, ischemic stroke; SAH, subarachnoid hemorrhage; SCI, silent cerebral infarction; STR, stroke; TIA, transient ischemic attack.
†alc, alcohol; anx, anxiety; BMI, body mass index; BP, blood pressure or hypertension; car, access to car; chETS, childhood ETS; chol, cholesterol; depriv, deprivation; dfat, dietary fat; diab, diabetes; educ, education; FEV1, forced expiratory volume in 1 second; HDL, high density lipoprotein; hins, health insurance; histSH, history (or family history) of stroke or heart disease; hormt, hormone therapy; hqual, housing quality; hten, housing enure; hyplip, hyperlipidemia; inc, income; obesity or weight; marst, marital status; menop, menopausal status; occ, occupation; OCs, oral contraceptives; peduc/occ, parental education/occupation; phys, physical activity; proxr, proxy respondent; race, race or ethnicity; reg, region; soccl, social class; trig, triglycerides; wcell, white cell count. Numbers in brackets indicate where more than one variable was used.
‡Underlined RRs and CIs used in principal meta-analysis. This table includes all available "most adjusted" RRs for exposure types, spouse, household, and total (except spouse-past results for studies).
§Race, phys, dfat, alc, BP, diab, HDL, trig, and BMI. ‖Reg, soccl, phys, alc, height, BP (2), chol (2), FEV1, BMI, trig, wcell, diab, and histSH. ¶Comparison is with spouse nonsmoker. Results also available for spouse-current versus spouse-never smoker, and for spouse-past versus spousenever smoker.
#Educ, occ, inc, phys, alc, BMI, menop, hormt, OCs, BP (2), diab, and aspirin. **Age squared, race (2), reg, peduc/occ (3), educ, income, alc, BMI (2), BP, diab, and histSH. † †Results were stated to be unaffected by additional adjustment for diet (2) and alc. ‡ ‡Reg, soccl, phys, alc, BMI, BP (2), chol, HDL, trig, FEV1, CRP, IL-6, wcell, and diab. § §This study only provided results in the form of counts of cases and controls exposed and unexposed to ETS from which it was possible to calculate an RR (95% CI). As this was unadjusted, it was not included in meta-analyses.
‖‖Reg, hins, alc, diet (5), BMI, BP, diab, and chETS (2). ¶ ¶Race, age × race, educ, inc, phys, alc, BMI, BP (2), diab, histSH (3).
further in this section or in the meta-analyses. The adjusted estimates range from .25 to 3.30, with 13 (in nine studies) significantly above 1.00 and one further estimate being of borderline significance. Three estimates, all from the same study, 16 were significantly below 1.00. The estimates are all adjusted for age, and the sexes combined estimates all adjusted for sex. Other factors adjusted for in at least five studies were blood pressure, diabetes, alcohol consumption, obesity or weight, education, exercise or physical activity, history of heart disease, cholesterol or triglycerides, income, occupation, marital status, race, and region within study. Sixteen of the 26 studies adjusted for at least eight variables.
Underlined in Table 2 are the 39 RR (CI) estimates used in the principal meta-analysis. Those estimates most nearly approximating to current spousal exposure were selected, but in practice the selected RRs from only 9 studies were for spousal exposure and only 14 for current exposure. The nonunderlined estimates include most of those used in sensitivity analyses. In 11 studies, 8, [12] [13] [14] 17, 20, 21, 25, 28, 32 data were only available for one exposure and one stroke end point, so no alternative RR could be included in the sensitivity meta-analyses. Table 3 presents the principal meta-analysis, together with subgroup analyses, based on the 39 RR estimates underlined in Table 2 . Further details of the analysis are given in Appendix S2. The fixed-effect metaanalysis shows a highly significant (P < .001) increased risk associated with ETS exposure, the overall RR being estimated as 1.23 (95% CI: 1.16-1.31). There was some evidence (P < .05) of heterogeneity between estimates, although the random-effects estimate was quite similar at 1.25 (1.14-1.36). Analysis by subgroup shows no significant variation in the RR estimate by sex, exposure index, study size, number of adjustment variables, fatality, and disease end point. The pattern in variation by region remains similar to that reported previously, with no significant increase in Europe, but the overall variation between regions is no longer significant. There is, however, significant variation by period of publication, with the RRs higher for studies published between 1990-1999 and 2005-2009 than for other periods, although no consistent trend is apparent. RRs are higher in case-control and cross-sectional than in prospective studies, although significantly increased RRs are seen for each study type. There is also significant variation by study inclusion criteria, with no significant increase seen in studies using the strict criterion of never smoking any tobacco, but a significant increase seen in studies including pipe-or cigar-only smokers, occasional smokers, or long-term ex-smokers. Although no significant variation is seen by disease end point, it is noteworthy that no significant elevated risk is seen for hemorrhagic stroke, either as a subgroup of the principal metaanalysis or when all eight available RRs are included (see footnote ‖ in Table 5 ).
There is no significant evidence of publication bias, based on the RR estimates included in the principal meta-analysis. Table 4 presents the results of various sensitivity metaanalyses, with further details shown in Appendix S2. There is little variation in overall estimates according to whether preferences were for ever rather than current exposure, or for total rather than spousal exposure, or whether the results for silent cerebral infarction, which may be regarded as not being stroke, were excluded.
There was also little variation in the estimates according to whether the RRs selected were those that were adjusted for the most potential confounding variables for which results were available (as in the data presented in Table 2 ) or were those that were adjusted for age and as few other variables as possible (see Appendix S2). In fact, only in 11 studies 13, 14, 19, 20, 22, 23, 25, 28, 33, 34 do the "most adjusted" and "least adjusted" estimates differ, and they are generally quite similar. Exceptionally, the estimate of 1.54 (.68-3.47) adjusted for age and 15 variables from the Whincup et al study 20 is substantially greater than the estimate of .96 (.49-1.89) adjusted only for age and region.
Three studies 24, 28, 31 provided RRs for workplace exposure. One of these 31 reported a significantly raised RR (2.34, 95% CI: 1.15-4.76) for all types of stroke, whereas all other estimates were nonsignificant, including dose-response RRs of .47, .95, and .74 corresponding to 1-9, 10-24, and 25+ years of exposure, respectively. 24 Another study 9 merely reported no significant association. The fixed-effect estimate from combining the four available overall estimates is 1.12 (95% CI: .79-1.59) (details in Appendix S2). Two studies 24, 28 gave RRs for childhood exposure specifically, but no significant findings were reported. Other sources of exposure were rarely studied and never produced significant findings. Table 5 summarizes the dose-response results for the exposure indices most closely approximating to spousal exposure and for the most inclusive stroke category for which the results were available. Fourteen studies reported data, of which two merely reported the absence of a trend without presenting RRs, and one presented unadjusted data not included in the meta-analysis. In five studies, 15, 21, 23, 24, 27 there was a significant (P < .05) positive trend. Based on the results for the highest level of exposure reported, 14 estimates from 11 studies show a highly significant (P < .001) increased risk of stroke associated with ETS exposure (RR: 1.56, 95% CI: 1.37-1.79). Based on the results, for the lowest (positive) dose level, 12 estimates from 10 studies also show a significant (P < .01) increase (RR: 1.20, 95% CI: 1.04-1.37).
Discussion
Based on 39 estimates, from 28 studies, of the risk of stroke associated with current spousal ETS exposure, or the nearest equivalent available, our meta-analysis shows a highly significant positive relationship. For those 14 studies providing dose-response data, the highest level of exposure was associated with an even higher risk. Below, we consider various issues relevant to assessing these associations in terms of a causal relationship.
Consistency
Although the studies vary considerably in design, and in exposure and disease definition, and only 13 of the 39 estimates included are significantly (P < .05) increased, there is only modest evidence of heterogeneity in the meta-analysis. Nor does the overall estimate materially depend on the precise criteria used to choose the RRs to be analyzed (see Table 4 ), although only about half of the studies provide a choice of estimates. Subgroup analyses do suggest some possible sources of variability, with a smaller increase in RR in prospective studies than in other study designs, although the Abbreviations: CI, confidence interval; CVD, cerebrovascular disease; RR, relative risks. *From fixed-effect analysis unless stated. Random-effects estimates were generally similar. †The heterogeneity chi-square was 58.92 on 38 d.f., P < .05. ‡Differences in RR between levels of the factor studied significant at P < .05. §Factors adjusted for except for sex. ‖Includes ASH, HS, and SAH as defined in Table 2 . The fixed-effect estimate based on all eight available estimates is 1.09 (.85-1.40). ¶Includes IST and SCI as defined in Table 2 . The fixed-effect estimate based on all nine available estimates is 1.15 (1.00-1.33). #The levels are (1) never smoked any tobacco product or never smoked not otherwise specified; (2) never smoked cigarettes; (3) never smoked cigarettes, or smoked cigarettes for no more than a defined period (3 months or 6 months), or smoked no more than 100 cigarettes in lifetime; and (4) other definitions allowing occasional smokers or those who quit smoking at least 5 year ago.
increase is still statistically significant even for prospective studies. Variation by year of publication, although significant and showing no elevated risk in the most recently published studies (2010-2015), does not indicate any overall time trend in risk. Although the variation by study inclusion criteria is significant, showing a lower risk in studies using a stricter never smoking definition, it seems implausible that the inclusion of pipe-or cigaronly smokers would have had much real effect, given the rarity of such smoking in most populations, particularly among women. However, with the minor exception of the results for hemorrhagic stroke, some elevated risk (although not always significant) is seen in every other subgroup, indicating a fair degree of consistency.
Comparison with Other Reviews
An RR estimate of 1.45 published in 2005 37 was based on the median from only seven studies.
The results from our review published the next year 1 were based on 16 studies and differed a little from the present results, the fixed-effect estimate from that principal analysis being slightly higher (1.25) and the randomeffects estimate slightly lower (1.23) than the estimates reported here (1.23 and 1.25, respectively; Table 3 ). A more recent review, by Oono et al, 3 published in 2011, was based on 35 estimates from 20 studies, and gave an overall risk estimate of 1.25 (95% CI: 1.12-1.38), which is similar to ours. The authors also noted that there was evidence of a dose relationship, with RRs rising from 1.16 (95% CI: 1.06-1.27) for exposure from five cigarettes per day to 1.56 (95% CI: 1.25-1.96) for 40 cigarettes per day. The authors concluded that "there is evidence of a strong, consistent and dose-dependent association between exposure to secondhand smoke and risk of stroke, suggestive of a causal relationship, with disproportionately high risk at low levels of exposure suggesting no safe lower limit of exposure." Although there is considerable correspondence between the sets of data used by Oono et al and us, we note that their dose-response analyses were based solely on those three studies that presented risk using cigarettes per day as the index of ETS exposure, 15, 23, 27 and used a model involving fitting linear and quadratic terms to the limited data, where the mean exposure associated with the final open-ended interval is unclear.
In 2014, the U.S. Surgeon General published a report 2 that included a section on secondhand smoke exposure and stroke risk. The main conclusions were that "the evidence is sufficient to infer a causal relationship between exposure to secondhand smoke and increased risk of stroke" and that "the estimated increase in risk for stroke from exposure to secondhand smoke is about 20-30%." The report's section on ETS and stroke was based heavily on the meta-analysis in 2011 by Oono et al, discussed above, and although more recent studies were mentioned they were not included in meta-analyses. The authors of the report noted that Oono et al did not make any formal assessment of the quality of the studies included in their meta-analysis and that variations in the quality of exposure assessment meant there was potential for recall bias in some studies. Additionally, it was stated that although there was no evidence of publication bias among the studies included in the metaanalysis, the possibility of additional negative findings that have never been published cannot be ruled out. A more recent review, in 2015, 38 concerned only seven studies, having rejected a further five following quality assessment. Overall, the risk of stroke in subjects exposed to ETS was estimated at 1.35 (95% CI: 1.22-1.50), somewhat higher than our estimate. Considering that our estimate is based on 39 results from 28 studies, the search procedures, which did not seem to involve study of reference lists in earlier reviews, seem seriously inadequate.
In addition, numerous studies have examined the change in stroke incidence following the introduction of smokefree legislation. A meta-analysis in 2012 39 reported a significant reduction in hospital admissions for stroke following the introduction of smoke-free laws, estimating an RR of .795 (95% CI: .68-0.93). A comprehensive review published in 2016 40 reported results from six studies, four Abbreviations: CI, confidence interval; RR, relative risks. *Using preference order for time of exposure: ever, during marriage, in the past, in the last 5 or 10 years, and current. †Using preference order for type of exposure: total, cotinine, spouse, and household. ‡P < .05. published after the above meta-analysis. All found evidence of a reduction in stroke admissions following smoking bans. However, the relevance of these reports is questionable as studies of smoking bans are typically not restricted to nonsmokers, so do not specifically determine the effect of ETS. As well as reducing ETS exposure, bans are likely to reduce opportunities for active smokers to smoke, and hence their daily consumption. Various potential sources of bias are now considered.
Misclassification of the Subject's Smoking Status
It is well established that some smokers deny current or past smoking on interview, and that smokers are more likely to be married to (or live or work with) smokers. 41, 42 Together, these facts imply that studies of self-reported never smokers may observe that ETS increases risk of a smoking-related disease caused by smoking even where no true risk exists. 43 This "misclassification bias" has been widely discussed for lung cancer, although opinions differ as to its importance. 42, [44] [45] [46] [47] As smoking is more weakly associated with stroke than lung cancer, such bias will be less important, but deserves some attention. Some papers considering this type of bias were Hill et al, 25 who only considered misclassification of the subjects' smoking status in relation to their all-cause mortality results, concluding that the bias was canceled out by greater misclassification of out-of-home ETS among never smokers, He et al, 31 who considered that collection of smoking data on two occasions 18 years apart is sufficient to minimize this source of bias, and Nishino et al, 33 who asserted that the effect of this misclassification was limited because of the low prevalence of smoking in the cohort analyzed. The only two studies 20, 29 attempting to confirm nonsmoking status were those that used cotinine both to quantify ETS exposure and exclude current smokers, although even this method cannot rule out failure to report past smoking.
Confounding
In principle, risk factors associated with both stroke and with ETS exposure can confound the association of interest. Although all but one study took account of age and sex, they varied considerably in the other stroke risk factors adjusted for. Whereas some studies [8] [9] [10] 17, 21 adjusted for no, or very few, additional variables, others 13, 16, [18] [19] [20] [23] [24] [25] [26] [27] 29, [31] [32] [33] [34] took into account quite an extensive list, in at least some analyses. Our analyses do not suggest such adjustment had any major effect on the RR estimate (except perhaps for one study, 20 although the data as presented do not allow the effects of adjustment for 35, 36 P value coded as ***P < .001, **.001 < P < .01, *.01 < P < .05, (*).05 < P < .1, NS P ≥ .1.
‡Summing "not at all" = 0, "little" = 1, "average" = 2, and "a lot" = 3 for self-reported exposure to ETS at home, at work, during travel, and during leisure.
§Exceptionally, results for females are shown both for household and total exposure, this being the only instance where there was a choice of exposure type. Household exposure is used in the meta-analysis.
‖RRs are unadjusted and are not included in meta-analyses. ¶Cigs/day used in meta-analysis. #Summing scores of 0-3 for home (based on pack-years) and work (based on cigarettes per day, years, smokers, and hours per day).
specific variables to be quantified). As we discussed earlier, 1 adjustment for blood pressure, a strong predictor of stroke, could be unjustified due to overmatching.
Publication Bias
Techniques to evaluate publication bias are quite insensitive, and the fact that our principal and sensitivity analyses showed no statistically significant publication bias does not necessarily mean that failure to publish relevant findings has not materially affected our metaanalyses. Many prospective studies have reported results for ETS and other major smoking-associated diseases, such as lung cancer and heart disease, but not for ETS and stroke, and might reasonably have been expected to do so had any relationship been found, for example in LeVois and Layard, Steenland 
Recall Bias
Because the presence of, or knowledge of, the disease may affect reporting of exposure, there is potential for recall bias in case-control and cross-sectional studies. The observation of higher RRs in studies of these designs than in prospective studies (see Table 3 ) tends to support this possibility.
Study Weaknesses
As we noted earlier, various study weaknesses are common. These include reliance on diagnosis on death certificates 8, 10, 12, 17, 21, 24, 25, 28, 31 or on unconfirmed subject report 16, 23, 26, 30 ; not allowing for possible changes in ETS exposure and other risk factors during follow-up in longterm prospective studies 10, 12, 17, 20, 22, 28, 33, 34 ; reliance, except in two studies, 20, 29 on unconfirmed subjective assessment of ETS exposure; use of proxy respondents 11, 14, 18, 21, 32 ; failure to restrict attention to ETS exposure before disease onset 16, 23 ; and failure to restrict attention to married subjects when analyzing spousal exposure 11, 15, 24, 29 or to control for household size when analyzing household exposure (no studies did).
It should also be noted that case-control studies of survivors from stroke 9, 15 and prospective studies of fatal cases 8, 10, 12, 17, 24, 25, 28, 31, 33 inaccurately assess the effect of ETS exposure to stroke onset, as possible effects on survival are also involved.
Problems relating to specific studies also deserve comment. Thus, the New Zealand case-control study 14 used proxies only for the cases and controls with an age distribution markedly different from the cases, and the Greek case-control study 32 also used proxies only for the cases. Most notably, as discussed in detail previously, 1 the Hong Kong case-control study 21 had a very unusual design that produced implausible findings possibly biased by their inappropriate control group.
Conclusion
Several recent reviews 2, 3, 38 have reported a significantly increased risk of stroke in subjects exposed to ETS, with one 2 inferring a causal relationship. Our updated meta-analysis also shows a statistically significant increase, with larger increases at higher ETS exposures. However, there are concerns about possible biases, particularly publication bias and recall bias, and also about study weaknesses. In our opinion, the findings are suggestive of, but do not conclusively demonstrate, a causal relationship. There remains a need for additional large well-designed studies of incident stroke to be conducted. We also repeat our suggestion made 10 years ago for results relating ETS to stroke to be published using data from a number of very large prospective studies for which findings for other diseases have been reported.
